Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Marchetti

Showing results (301-310 of 318) with videos related to

Pageof 32
Sort By:
Gynecologic Oncology|September 7, 2016
Adjuvant chemotherapy does not improve disease-free survival in FIGO stage IC ovarian granulosa cell tumors: The MITO-9 studyG Mangili, J Ottolina, G Cormio, et al.
International Journal of Cancer|May 29, 2025
Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population dataPierluca Piselli, Alessandro Tavelli, Claudia Cimaglia, et al.
ESMO Open|December 20, 2024
Actionable mutations in early-stage ovarian cancer according to the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT): a descriptive analysis on a large prospective cohortF Camarda, L Mastrantoni, C Parrillo, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|November 1, 2015
PARP inhibition: A promising therapeutic target in ovarian cancerA Musella, C Marchetti, M L Gasparri, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|April 1, 1997
Accuracy of cholesterol measurements in Italian clinical laboratories. Joint project GISSI prevention--Italian Society of Clinical Biochemistry. SIBioC GISSI Prevenzione GroupM S Graziani, F Ceriotti, A Carobene, et al.
Brain Stimulation|April 6, 2024
Robotic-electronic platform for autonomous and accurate transcranial magnetic stimulation targetingRenan H Matsuda, Victor H Souza, Thais C Marchetti, et al.
The Journal of Antimicrobial Chemotherapy|September 24, 2025
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO RegistryD Armenia, G Marchegiani, V Spagnuolo, et al.
ESMO Open|January 23, 2025
BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus StudyL Incorvaia, C Marchetti, C Brando, et al.
The Journal of Antimicrobial Chemotherapy|April 6, 2024
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohortAntonella d'Arminio Monforte, Alessandro Tavelli, Antonio Di Biagio, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 27, 2018
Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 studyA Bergamini, G Ferrandina, M Candiani, et al.
Pageof 32

Showing results (301-310 of 318) with videos related to

Sort By:
Pageof 32
Gynecologic Oncology|September 7, 2016
Adjuvant chemotherapy does not improve disease-free survival in FIGO stage IC ovarian granulosa cell tumors: The MITO-9 studyG Mangili, J Ottolina, G Cormio, et al.
International Journal of Cancer|May 29, 2025
Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population dataPierluca Piselli, Alessandro Tavelli, Claudia Cimaglia, et al.
ESMO Open|December 20, 2024
Actionable mutations in early-stage ovarian cancer according to the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT): a descriptive analysis on a large prospective cohortF Camarda, L Mastrantoni, C Parrillo, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|November 1, 2015
PARP inhibition: A promising therapeutic target in ovarian cancerA Musella, C Marchetti, M L Gasparri, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|April 1, 1997
Accuracy of cholesterol measurements in Italian clinical laboratories. Joint project GISSI prevention--Italian Society of Clinical Biochemistry. SIBioC GISSI Prevenzione GroupM S Graziani, F Ceriotti, A Carobene, et al.
Brain Stimulation|April 6, 2024
Robotic-electronic platform for autonomous and accurate transcranial magnetic stimulation targetingRenan H Matsuda, Victor H Souza, Thais C Marchetti, et al.
The Journal of Antimicrobial Chemotherapy|September 24, 2025
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO RegistryD Armenia, G Marchegiani, V Spagnuolo, et al.
ESMO Open|January 23, 2025
BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus StudyL Incorvaia, C Marchetti, C Brando, et al.
The Journal of Antimicrobial Chemotherapy|April 6, 2024
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohortAntonella d'Arminio Monforte, Alessandro Tavelli, Antonio Di Biagio, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 27, 2018
Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 studyA Bergamini, G Ferrandina, M Candiani, et al.
Pageof 32